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Delusional infestation is an aspeciﬁc psychiatric condition manifested either as a primary psychotic disorder or a secondary
disorder induced by a wide range of very diﬀerent medical conditions. Both primary and secondary delusional infestations seem
to respond to typical and atypical antipsychotics. The latter are considered the ﬁrst-line treatment although the use of second-
generationantipsychoticsfeaturingahighermetabolic,cardiovascular,andrenaltolerabilityispreferableinsecondarycases,which
often occur in patients with multiple, severe medical conditions. We report a case of a 72-year-old patient aﬀected by delusional
infestationassociatedwithsevererenalfailure,metabolicsyndrome,hypertensivecardiopathy,andchroniccerebrovasculardisease.
1.Background
The term of delusional parasitosis or delusional infestation
is used to describe psychotic cases of varying origin. Brieﬂy,
the disorder is characterized by the patient’s delusional belief
that his/her skin and other body areas are infested by small,
vivid, or less frequently inanimated pathogens, associated
to a series of abnormal body sensations [1, 2]. Two main
forms of the disorder have been reported to date, namely,
a “primary,” isolated monosymptomatic delusional disorder
[3], generally considered a “delusional disorder, somatic
type,” according to DSMIVTR [4], and a “secondary” form
which may be related to other psychiatric illnesses, toxic or
medication-induced psychoses, organic brain disorders, or
other general medical conditions. The “secondary” forms
aregenerally,althoughnonexclusively,includedamong“psy-
chotic disorder due to general medical condition” according
to DSMIVTR [4]. Both “primary” and “secondary” forms
seem to respond well to antipsychotic treatment, with either
“typical” or “atypical” agents [5–7] although the lack of ran-
domized controlled trials and head-to-head comparisons
prevents the drawing of any conclusions as to whether the
ﬁrst-generation drugs are superior in terms of eﬃcacy com-
pared to second-generation antipsychotics [2]. Aripiprazole,
an “atypical” antipsychotic, was recently suggested as one
of the most promising therapeutical tools in similar cases,
mainly due to its pharmacokinetic properties and its fairly
good tolerability [8]. Unfortunately, this drug has been used
in a limited number of studies to date, and the ﬁndings are
based upon only a few case reports [9–12]. Here, we report
the outcome of a case of delusional infestation in a patient
aﬀected by renal failure and chronic cerebrovascular disease
treated by means of aripiprazole after an unsuccessful trial
with risperidone.
2. Case Presentation
A Caucasian male patient, 72 years old, married, and retired,
was taken in care in the Community Mental Health Center
of Cagliari University (Italy) with a provisional diagnosis of
“psychogenic pruritus” upon referral from his family physi-
cian. His medical history showed that he had been affected
by a chronic nonobstructive pulmonary disease for an un-
speciﬁed period of time, had manifested insulin-dependent
diabetes mellitus type 2 in 1998 and onset of significant
renal failure in 2004 (currently on dialysis), and had been
diagnosed with hypertension and hypertensive heart disease
in2008. Thepatienthadmoreoverundergoneprostatectomy2 Case Reports in Medicine
in 2004 and removal of a non-otherwise-speciﬁed “cyst” of
the right breast in 2007. At the time of his ﬁrst appointment,
he was taking repaglinide, insulin, calcium acetate, sodium
polystyrene, atorvastatin, doxazosin, amlodipine, and cloni-
dine. The family and personal history of psychopathology
wastotallynegative.Thesymptomsforwhichhewasreferred
to our outpatient clinic had apparently started following a
bout of inﬂuenza two years previously (2008). In particular,
the patient experienced an intense skin itching associated
with the belief that an unspeciﬁed insect had laid eggs in
various areas of the body, speciﬁcally in the skin and in
various body cavities (nose, ears, and mouth). Furthermore,
he maintained that he could see and feel small animals and
pests everywhere although his wife denied ever having seen
these animals. The patient was aﬀected by skin lesions due
to continuous scratching and manifested an obsessive search
for “proof” of infestation, inspecting linens, clothing, and
skin folds although he was somewhat upset at not having
been ever able to catch the parasites to “show them to the
doctors.” The patient was referred to our centre following
repeated dermatologic examinations and skin tests, all of
which were negative. Signiﬁcant laboratory ﬁndings were
mild anaemia (11.4gr/dL), slight decrease in hematocrit
(32.4%), phosphorus (4.8mg/dL), potassium (5.5mEq/L),
gammaGT (66U/L), and increases in TRF (193mg/dL), urea
(171mg/dL), creatinine (6.5mg/dL) triglycerides (242mg/
dL), ferritin (451.8ng/mL), and PTH (216pg/mL) and fast-
ingglucose(212mg/dL).LevelsoffolicacidandVit.B12were
normal, and hepatitis markers were negative. Doppler ultra-
sound of the supra-aortic vessels showed an atherosclerotic
plaque located on the proximal left common carotid causing
a local stenosis of 35% and other nonstenosing plaques on
the middle part of the left common carotid and carotid
bifurcation bilaterally. The ECG was normal except for a
s l i g h tl e f ta x i sd e v i a t i o n( Q R Sa x i s<20). Echocardiogram
revealed a slight thickening of the left ventricle, while
aortic arch and ascending aorta were at the upper limit of
normality, and a minimal tricuspid insuﬃciency and a mild
aortic valve sclerosis were detected with a normal systolic
function (EF 60%). Chest X-ray showed a small ﬁbrotic
nodule in the left lateral-basal area, and a ﬂattening of the
diaphragm. CT scan of the brain revealed the presence of
residual signs of a left, nucleocapsular ischemic lesion, while
MRI showed diﬀerent areas of altered signal, hyperintense
in FLAIR, and T2 and DP, in the periventricular white
matter, in frontoparietal subcortical left and right areas and
semioval centers due to chronic vascular hypoperfusion,
in addition to expansion of the ventricular system and of
cortical and cisternal spaces due to cerebral atrophy. Psychi-
atric evaluation conﬁrmed the presence of a pervasive delu-
sionofinfestationassociatedwithsomaticandvisualhalluci-
nations. Nonsigniﬁcant cognitive impairment on Mini Men-
tal State Examination (MMSE) was evidentiated (total score
= 27). Fromtheend ofJuly 2010, thepatient wastreatedwith
oral risperidone, 1mg initially; after approximately a month,
thedosewasincreasedto2mgduetoscarceeﬃcacy.Approx-
imately one month later, a slight improvement was observed
(delusions were less pervasive and disturbing, and itching
was reduced). However, after two months of treatment,
risperidone was gradually withdrawn due to an increasing
sedation and to the absence of further clinical improvement.
As a replacement oral aripiprazole was gradually introduced,
10mg daily initially, being increased after 2 weeks to 15mg
daily. After four weeks, the clinical picture was considerably
improved, with disappearance of delusions, hallucinations,
and itching, without recovery of insight. Probably due to this
reason, for some months the patient made repeated requests
to discontinue therapy, deeming it useless. He accepted,
however, to continue, maintaining the same dosage as main-
tenance therapy. The only side eﬀect attributable to the in-
troduction of aripiprazole appeared after the ﬁrst two weeks
of treatment, in terms of a midterminal insomnia, which
required additional treatment with quetiapine 12.5mg for
approximately a month; after this period, the drug was sus-
pended, but sleep remained fairly good. Over the following
months, no recurrence of psychotic symptoms was observed,
but lack of retrospective insight remained. Accordingly, and
given the fact that therapy was well tolerated (no signiﬁcant
side eﬀects, modiﬁcation of laboratory test, or ECG were
detected), it was decided to continue maintenance treatment
with aripiprazole 15mg daily. After 10 months of treatment,
the patient is in a stable condition.
3. Discussion
The case described could be considered a secondary form
of delusion of infestation, in the light of the presence of
several major diseases which have been reported in literature
as associated with delusional parasitosis although in practice
it can sometimes be diﬃcult to determine whether a case
is a primary monosymptomatic delusional disorder or sec-
ondary to an organic pathology. Indeed, a seminal review
undertaken by by Freundenmann and Lepping [2]r e p o r t s
6 cases associated with hypertension, 23 cases associated
with other forms of cerebrovascular disease (mainly arte-
riosclerosis), 7 cases associated with diabetes mellitus, and
3 cases associated with renal failure; moreover, a recent case
in a patient aﬀected by renal failure and cerebral atrophy
was described by Tzeng and Chiang [12]. Naturally, in a
case such as that here described, characterized by multiple
medical diseases, it is impossible to determine exactly which
disease may have triggered the onset of delusional disorder.
Notwithstanding the limits of our knowledge on the eﬀec-
tiveness of antipsychotic drugs, based almost solely on case
series and case reports, both primary and secondary forms
of the disorder seemed to respond to the administration of
either typical or atypical antipsychotics [5–7], emphasizing
nowell-deﬁnedsuperiorityofoneovertheother.Inthiscase,
as the patient was aged and featured multiple problems, the
administration of pimozide and haloperidol had been ruled
out,particularlyinviewoftheiracknowledgedissuesrelating
to cardiovascular tolerability. Thus, risperidone was selected,
largely due to its low-risk proﬁle in patients with heart
disease, metabolic syndrome, or renal failure and to reports
maintaining the higher eﬃcacy of risperidone in secondary
forms [2]. Unfortunately, the lack of a signiﬁcant clinical
response within two months and the problems of tolerance
(excess of sedation) induced us to replace risperidoneCase Reports in Medicine 3
treatment. Aripiprazole was subsequently prescribed on the
basis of its good tolerability proﬁle with regard particu-
larly to the cardiovascular, metabolic, and renal function.
An increased adherence of the patient to treatment was
moreover hoped for in view of the good tolerability of the
drug. The switch was eﬀective, and a remission of psychotic
symptoms was achieved in approximately two months. This
timespan was in agreement with the average of approxi-
mately six weeks reported in literature as being necessary to
achieve similar results [2] although Tzeng and Chiang [12]
reportedanextremelyrapidclinicalresponse(approximately
two weeks) in a very similar case. At clinical regimen, the
dose administered was15mdaday,inline withotherreports
[9, 11, 13, 14] prescribing doses ranging between 10 and
30mg, but in contrast with the low dose (5mg) used in the
above-cited case by Tzeng and Chiang [12] and with the
case described by Freudenrich et al. [15]. On continuation
of treatment, minimal transient side eﬀects were reported
(insomnia), thus conﬁrming the eﬃcacy and tolerability
proﬁle reported previously, even in patients with particularly
compromised general conditions such as the case described
here [12, 15]. However, it should be underlined that clinical
remission in the patient studied cannot be considered com-
plete, as he continues to lack any true retrospective insight.
This ﬁnding is supported by reports present in literature
which have demonstrated that even patients treated success-
fully with pimozide, considered the gold standard treatment
for this condition for a considerable period, failed to recover
their insight [14].
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